share_log
Reuters ·  Apr 30 08:49
NRX Pharmaceuticals Shares Fall 20.9% Premarket as Depression Drug Fails to Reach Statistical Significance in Reducing Risk of Suicide in Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment